BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 27978469)

  • 1. Highly sensitive LC-MS/MS methods for the determination of seven human CYP450 activities using small oral doses of probe-drugs in human.
    Grangeon A; Gravel S; Gaudette F; Turgeon J; Michaud V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():144-158. PubMed ID: 27978469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of bupropion, metroprolol, midazolam, phenacetin, omeprazole and tolbutamide in rat plasma by UPLC-MS/MS and its application to cytochrome P450 activity study in rats.
    Ma J; Wang S; Zhang M; Zhang Q; Zhou Y; Lin C; Lin G; Wang X
    Biomed Chromatogr; 2015 Aug; 29(8):1203-12. PubMed ID: 25582505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid determination of five probe drugs and their metabolites in human plasma and urine by liquid chromatography/tandem mass spectrometry: application to cytochrome P450 phenotyping studies.
    Yin OQ; Lam SS; Lo CM; Chow MS
    Rapid Commun Mass Spectrom; 2004; 18(23):2921-33. PubMed ID: 15529418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity liquid chromatography-tandem mass spectrometry for the simultaneous determination of five drugs and their cytochrome P450-specific probe metabolites in human plasma.
    Oh KS; Park SJ; Shinde DD; Shin JG; Kim DH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():56-64. PubMed ID: 22483397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A liquid chromatography-tandem mass spectrometry analysis of nine cytochrome P450 probe drugs and their corresponding metabolites in human serum and urine.
    Puris E; Pasanen M; Gynther M; Häkkinen MR; Pihlajamäki J; Keränen T; Honkakoski P; Raunio H; Petsalo A
    Anal Bioanal Chem; 2017 Jan; 409(1):251-268. PubMed ID: 27734142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A UHPLC-MS/MS method coupled with liquid-liquid extraction for the quantitation of phenacetin, omeprazole, metoprolol, midazolam and their metabolites in rat plasma and its application to the study of four CYP450 activities.
    Wang Z; Sun W; Lin ZF; Sun R; Huang CK; Ye WJ; Dong YY; Zhang XD; Chen RJ
    J Pharm Biomed Anal; 2019 Jan; 163():204-210. PubMed ID: 30317077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of tolbutamide, omeprazole, midazolam and dextromethorphan in human plasma by LC-MS/MS--a high throughput approach to evaluate drug-drug interactions.
    Zhang W; Han F; Guo P; Zhao H; Lin ZJ; Huang MQ; Bertelsen K; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1169-77. PubMed ID: 20378422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of an absolute protein assay for the simultaneous quantification of fourteen CYP450s in human microsomes by HPLC-MS/MS-based targeted proteomics.
    Grangeon A; Clermont V; Barama A; Gaudette F; Turgeon J; Michaud V
    J Pharm Biomed Anal; 2019 Sep; 173():96-107. PubMed ID: 31125949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of nine drugs and their cytochrome P450-specific probe metabolites from urine by liquid chromatography-tandem mass spectrometry utilizing sub 2 microm particle size column.
    Petsalo A; Turpeinen M; Pelkonen O; Tolonen A
    J Chromatogr A; 2008 Dec; 1215(1-2):107-15. PubMed ID: 19019380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved cytochrome P450 phenotyping cocktail with a simplified and highly sensitive UHPLC-MS/MS assay in human plasma.
    Eagles SK; Wang X; Gross AS; McLachlan AJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():122013. PubMed ID: 32050158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A UPLC-MS/MS assay of the "Pittsburgh cocktail": six CYP probe-drug/metabolites from human plasma and urine using stable isotope dilution.
    Stewart NA; Buch SC; Conrads TP; Branch RA
    Analyst; 2011 Feb; 136(3):605-12. PubMed ID: 21107456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 substrate drugs and their metabolites.
    Tanaka S; Uchida S; Inui N; Takeuchi K; Watanabe H; Namiki N
    Biol Pharm Bull; 2014; 37(1):18-25. PubMed ID: 24389476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a LC-MS/MS method based on a new 96-well Hybrid-SPE™-precipitation technique for quantification of CYP450 substrates/metabolites in rat plasma.
    Ardjomand-Woelkart K; Kollroser M; Li L; Derendorf H; Butterweck V; Bauer R
    Anal Bioanal Chem; 2011 Jun; 400(8):2371-81. PubMed ID: 21225250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid chromatography/tandem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping studies in rats.
    Zhang S; Song N; Li Q; Fan H; Liu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(1):78-89. PubMed ID: 18614408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified analytical method for a phenotyping cocktail of major CYP450 biotransformation routes.
    Jerdi MC; Daali Y; Oestreicher MK; Cherkaoui S; Dayer P
    J Pharm Biomed Anal; 2004 Sep; 35(5):1203-12. PubMed ID: 15336365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UPLC-MS-MS method for simultaneous determination of caffeine, tolbutamide, metoprolol, and dapsone in rat plasma and its application to cytochrome P450 activity study in rats.
    Liu Y; Li X; Yang C; Tai S; Zhang X; Liu G
    J Chromatogr Sci; 2013 Jan; 51(1):26-32. PubMed ID: 22695883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and analytical development of the CIME cocktail for drug fate assessment in humans.
    Videau O; Delaforge M; Levi M; Thévenot E; Gal O; Becquemont L; Beaune P; Bénech H
    Rapid Commun Mass Spectrom; 2010 Aug; 24(16):2407-19. PubMed ID: 20658680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocktail approach for in vivo phenotyping of 5 major CYP450 isoenzymes: development of an effective sampling, extraction, and analytical procedure and pilot study with comparative genotyping.
    Wohlfarth A; Naue J; Lutz-Bonengel S; Dresen S; Auwärter V
    J Clin Pharmacol; 2012 Aug; 52(8):1200-14. PubMed ID: 21885687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Storage stability study of porcine hepatic and intestinal cytochrome P450 isoenzymes by use of a newly developed and fully validated highly sensitive HPLC-MS/MS method.
    Schelstraete W; Devreese M; Croubels S
    Anal Bioanal Chem; 2018 Feb; 410(6):1833-1843. PubMed ID: 29327113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a six-probe cocktail (caffeine, tolbutamide, omeprazole, dextromethorphan, midazolam, and digoxin) approach to estimate hepatic drug detoxification capability and dosage requirements after a single oral dosing in healthy Chinese volunteers.
    Koo SH; Soon GH; Pruvost A; Benech H; Ang TL; Lee EJD; Ang DSW
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jul; 395(7):815-826. PubMed ID: 35394133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.